Giner Life Sciences

Giner Life Sciences is a private U.S. healthcare technology company developing electrochemical oxygenation systems for medical and life science applications. Its core focus is miniature oxygen-generation devices for implantable and wearable use cases, including oxygenated cell-therapy systems and oxygenation devices intended to improve wound healing. The company's best-described lead effort is an implantable oxygenated cell therapy capsule for diabetes, designed to support transplanted insulin-producing cells by generating oxygen in situ. Giner Life Sciences appears to operate as a platform-oriented medical technology venture built on Giner's electrochemical engineering expertise rather than as a traditional therapeutics developer with a broad clinical pipeline. Based on publicly available information, its programs remain at the preclinical/R&D stage.